Abstract
Single amino acid Arg (arginine) deprivation is currently considered as a therapeutic approach to treat certain types of tumours; the molecular mechanisms that underlie tumour cell sensitivity or resistance to Arg restriction are still little understood. Here, we address the question of whether endogenous levels of key Arg metabolic enzymes [catabolic: arginases, ARG1 (arginase type 1) and ARG2 (arginase type 2), and anabolic: OTC (ornithine transcarbamylase) and ASS (argininosuccinate synthetase)] affect cellular responses to arginine deprivation in vitro. Human epithelial cancer cells of different organs of origin exhibiting variable sensitivity to Arg deprivation provided the experimental models. Neither the basal expression status of the analysed enzymes, nor their changes upon arginine withdrawal correlated with cancer cell sensitivity to arginine deprivation. However, the ability to utilize exogenous Arg precursors (ornithine and citrulline) for growth in Arg-deficient medium strongly correlated with expression of the corresponding enzymes, OTC and ASS. We also observed that OTC expression was below the level of detection in all the types of tumour cells analysed, suggesting that in vitro, at least for them, Arg is an ess...Continue Reading
References
Dec 1, 1977·Analytical Biochemistry·G L Peterson
Jun 6, 2000·FEBS Letters·J H YoonC Y Kim
Apr 24, 2003·European Journal of Biochemistry·Annie HussonAlain Lavoinne
Feb 11, 2004·Cancer·Brian J DillonMike A Clark
May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francesco IzzoSteven A Curley
May 12, 2005·Seminars in Cancer Biology·Denys N Wheatley
Aug 23, 2005·Cancer Letters·Denys N WheatleyElaine Campbell
Oct 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paolo A AsciertoTheodore F Logan
Feb 14, 2006·The American Journal of Clinical Nutrition·Sidney M Morris
Nov 15, 2008·Journal of Leukocyte Biology·B-S ChoiP Kropf
Mar 31, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Evan S GlazerFrancesco Izzo
Citations
Sep 17, 2013·Amino Acids·Bozhena Vynnytska-MyronovskaOleh Stasyk
Feb 1, 2013·PloS One·James W WellsSlobodan Tepic
Jan 12, 2016·Experimental Cell Research·Bozhena O Vynnytska-MyronovskaOleh V Stasyk
Nov 8, 2015·The International Journal of Biochemistry & Cell Biology·Yaroslav BobakOleh Stasyk
May 1, 2015·Scientific Reports·Yan-Shen ShanYi-Ling Chen
Jun 8, 2011·International Journal of Cancer. Journal International Du Cancer·Bozhena Vynnytska-MyronovskaLeoni A Kunz-Schughart
Sep 19, 2014·Cell Biology International·Oleh V StasykAndriy A Sibirny
Jul 6, 2014·BioMed Research International·Galyna ShuvayevaCiro Isidoro
Apr 26, 2016·Oncogene·M D PatilD Fukumura
Nov 5, 2014·Amino Acids·Iuliia PavlykMaria Jolanta Redowicz
Nov 5, 2016·Expert Opinion on Therapeutic Patents·H S FernandesN M F S A Cerqueira
Oct 1, 2011·Anti-cancer Drugs·Vaidehi AgrawalArthur E Frankel
Feb 19, 2020·Cell Biology International·Galyna Y ShuvayevaOleh V Stasyk
Mar 22, 2020·Pharmaceutics·Larisa KolevaElena Sinauridze
Oct 4, 2017·Oncotarget·Ashley VardonFrancis Mussai
Oct 1, 2016·Oncotarget·Yuliya KurlishchukLeoni A Kunz-Schughart
Aug 16, 2018·Scientific Reports·Constantinos AlexandrouAlessandro Rufini
Nov 24, 2017·International Journal of Cancer. Journal International Du Cancer·Carmela De SantoFrancis Mussai
Dec 21, 2020·Nucleic Acids Research·Haissi CuiPaul Schimmel
Jan 30, 2021·Frontiers in Pharmacology·Ziyu WangDianwen Ju
Jun 17, 2021·Scientific Reports·Rósula García-NavasFaustino Mollinedo